Clinical Trial Update: Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating letrozole for prevention of breast cancer in postmenopausal women at high risk due to dense breast tissue has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED